News
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 14, ...
Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...
7h
Zacks.com on MSNTilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to KnowIn the latest trading session, Tilray Brands, Inc. (TLRY) closed at $0.61, marking a +1.21% move from the previous day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results